
Volatility Spikes As Rates Drop… And China’s Growing Chip Demand 10/16/25
CNBC's "Fast Money"
 00:00 
How crowded is the MASH (liver disease) drug market?
Madrigal CEO Bill Sibold explains ResDifera launch progress, market penetration, competition, and the large addressable patient opportunity.
 Transcript 
 Play full episode 


